Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients

PURPOSE: To study ocular surface disease (OSD) changes after switching from preserved prostaglandin analogues monotherapy to preserved tafluprost and preservative-free (PF) tafluprost in primary open-angle glaucoma patients. METHODS: Glaucoma patients treated with preserved prostaglandins (except ta...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Ophthalmol
Autori principali: Ruangvaravate, Ngamkae, Choojun, Karnthida, Srikulsasitorn, Benjawan, Chokboonpiem, Jatupol, Asanatong, Dechathon, Trakanwitthayarak, Supaporn
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548342/
https://ncbi.nlm.nih.gov/pubmed/33116362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S264984
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi